Drug Delivery

This group is located at the Helmholtz Institute for Pharmaceutical Research Saarland (HIPS)

While considering the confusing flood of drugs in the pharmacies it is hard to believe in a lack of medication. But there are still many infectious diseases and also cancer that cannot be treated sufficiently. During a medical treatment it is essential that the drug arrives at the envisaged body region. Read more about the research of the department “Drug Delivery” on techniques for the correct distribution of novel drugs.


Ongoing Research Projects

  • Development of a new in vitro model of the air-blood-barrier: IN VITRO MODEL
  • Needle-free transdermal vaccination: VACCINATION
  • Drug-loaded nano- and microparticles for the treatment of inflammatory bowel diseases: TREATMENT
  • Design of new gene delivery carriers: DELIVERY CARRIERS
  • Helmholtz Drug Research Initiative: DRUG RESEARCH
  • Bioengineered microfluidic in vitro test system to study alveolar transport and clearance: LUNG-ON-A-CHIP
  • Antibiotika-beladene Nanocarrier zur Therapeutischen Inhalation gegen Tuberkulose; Teilvorhaben: Optimierung der Wechselwirkungen mit dem Flüssigkeitsfilm der Lunge und Entwicklung einer Pulverformulierung zur Inhalation der Antibiotika-Nanocarrier Syste: ANTI-TB
  • New nanotherapy research for inflammatory bowel diseases: NEWDEAL
  • Design and Development of advanced NAnomedicines to overcome Biological BArriers and to treat severe diseases: ITN NABBA

Finished Projects

  • Innovative, mechanistic-based strategies for delivery of therapeutic macromolecules across cellular and biological barriers: ITN PATHCHOOSER


Bachelor & Master
Are you interested in a bachelor or master thesis? We are looking forward to your request!


  • HIPS Infofilm (English)

    Resistance to antibiotics has become one of the major global challenges regarding infectious diseases. This is specifically the issue that is being tackled by the new Helmholtz-Institute for Pharmaceutical Research Saarland (HIPS).

Audio Podcast

  • Kleine Teile – große Wirkung: Pharmazeuten des HIPS schleusen Medikamente zielsicher durch den Körper Wie kommt ein Medikament dahin, wo es wirken soll? Das ist eine der zentralen Fragen bei der Entwicklung neuer Wirkstoffe. Denn es reicht nicht, ein tolles neues Medikament gegen Darminfektionen im Reagenzglas zu haben – es muss auch dort hin gelangen, wo die Krankheit stattfindet. Mit Transportmolekülen schleusen die Pharmazeuten des HZI diese Wirkstoffe durch unseren Körper – über Barrieren, durch passende Lücken und an gefährlichen Stellen vorbei. Besuchen Sie Claus-Michael Lehr und Brigitta Loretz am Helmholtz-Institut für Pharmazeutische Forschung Saarland (HIPS)…
PrintSend per emailShare